Rob Gaffey

Vice President, Finance and Administration

Rob Gaffey is Vice President of Finance and Administration at Cadent Therapeutics.  Mr. Gaffey was most recently Vice President of Finance and Corporate Controller at Merrimack Pharmaceuticals.  Previously he served as Vice President of Finance at Dimension Therapeutics where he played a lead role in the company’s initial public offering and was responsible for the integration and transition of finance after the company’s acquisition by Ultragenyx Pharmaceutical.  Prior to joining Dimension, Mr. Gaffey held positions of increasing responsibility at Moderna Therapeutics, Avila Therapeutics, Tolerx, Inc. and TIAX, LLC.  Mr. Gaffey began his career in finance in the assurance practice of the accounting firm Arthur Andersen, LLP, where he specialized in emerging life science and technology companies.  Earlier in his career, he was a research associate at Genzyme Corporation.

Mr. Gaffey received his M.S. in Accounting and M.B.A. from Northeastern University and his B.S. in Environmental Science from the University of Massachusetts Amherst.

Our Team

Rob Gaffey

Vice President, Finance and Administration

Rob Gaffey is Vice President of Finance and Administration at Cadent Therapeutics.  Mr. Gaffey was most recently Vice President of Finance and Corporate Controller at Merrimack Pharmaceuticals.  Previously he served as Vice President of Finance at Dimension Therapeutics where he played a lead role in the company’s initial public offering and was responsible for the integration and transition of finance after the company’s acquisition by Ultragenyx Pharmaceutical.  Prior to joining Dimension, Mr. Gaffey held positions of increasing responsibility at Moderna Therapeutics, Avila Therapeutics, Tolerx, Inc. and TIAX, LLC.  Mr. Gaffey began his career in finance in the assurance practice of the accounting firm Arthur Andersen, LLP, where he specialized in emerging life science and technology companies.  Earlier in his career, he was a research associate at Genzyme Corporation.

Mr. Gaffey received his M.S. in Accounting and M.B.A. from Northeastern University and his B.S. in Environmental Science from the University of Massachusetts Amherst.

Our Team

Rob Gaffey

Vice President, Finance and Administration

Rob Gaffey is Vice President of Finance and Administration at Cadent Therapeutics.  Mr. Gaffey was most recently Vice President of Finance and Corporate Controller at Merrimack Pharmaceuticals.  Previously he served as Vice President of Finance at Dimension Therapeutics where he played a lead role in the company’s initial public offering and was responsible for the integration and transition of finance after the company’s acquisition by Ultragenyx Pharmaceutical.  Prior to joining Dimension, Mr. Gaffey held positions of increasing responsibility at Moderna Therapeutics, Avila Therapeutics, Tolerx, Inc. and TIAX, LLC.  Mr. Gaffey began his career in finance in the assurance practice of the accounting firm Arthur Andersen, LLP, where he specialized in emerging life science and technology companies.  Earlier in his career, he was a research associate at Genzyme Corporation.

Mr. Gaffey received his M.S. in Accounting and M.B.A. from Northeastern University and his B.S. in Environmental Science from the University of Massachusetts Amherst.

Our Team